文献速递产科母胎医学

布洛芬与对乙酰氨基酚对重度子痫前期产后高血压的影响:双盲随机对照试验

Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2018-03-02

该双盲随机对照试验将100例重度子痫前期产妇随机分为产后每6小时口服布洛芬600 mg或对乙酰氨基酚650 mg组,发现两组严重范围高血压持续时间无差异(35.3 vs 38.0小时,P=0.30),结论认为布洛芬作为产后一线镇痛药并未延长严重范围高血压持续时间。

要点

  • 布洛芬组与对乙酰氨基酚组严重范围高血压持续时间无差异(35.3 vs 38.0小时,P=0.30)。
  • 两组次要结局包括平均动脉压、降压药使用、住院时间延长及阿片类药物使用均无差异。
  • 作者结论认为布洛芬作为产后一线镇痛药未延长重度子痫前期患者的严重范围高血压持续时间。

核心结论

  • 作者结论认为,在重度子痫前期女性中,产后一线使用布洛芬而非对乙酰氨基酚镇痛并未延长严重范围高血压的持续时间。

研究设计与样本

  • 双盲随机对照试验,在分娩时将重度子痫前期女性随机分配至产后每6小时口服布洛芬600 mg或对乙酰氨基酚650 mg组。
  • 给药自分娩后6小时内开始并持续至出院,突破性疼痛可按需使用阿片类镇痛药。
  • 评估154例女性,其中100例符合入组标准并随机化,7例交叉或未接受分配药物,93例按分配组完成研究方案。
  • 采用意向性分析原则分析所有结局数据。

主要发现

  • 布洛芬组与对乙酰氨基酚组严重范围高血压持续时间无差异(35.3 vs 38.0小时,P=0.30)。
  • 两组在分娩至末次血压≥150/100 mm Hg时间、产后平均动脉压、产后最大收缩压或舒张压、任何产后血压≥160/110 mm Hg、急性血压控制使用短效降压药、产后住院时间、因血压控制延长住院、出院时降压药使用及疼痛控制不足时阿片类药物使用等次要结局均无差异。
  • 在发生严重范围高血压患者的亚组分析中,对乙酰氨基酚组血压控制平均时间为68.4小时,布洛芬组为56.7小时(P=0.26)。
  • 产后6周时,两组在产科分诊就诊率、再入院率、持续阿片类药物使用或持续降压药使用方面均无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonsteroidal antiinflammatory drug use has been shown to increase blood pressure in nonpregnant adults. Because of this, the American College of Obstetricians and Gynecologists suggests avoiding their use in women with postpartum hypertension; however, evidence to support this recommendation is lacking. OBJECTIVE: Our goal was to test the hypothesis that nonsteroidal antiinflammatory drugs, such as ibuprofen, adversely affect postpartum blood pressure control in women with preeclampsia with severe features. STUDY DESIGN: At delivery, we randomized women with preeclampsia with severe features to receive around-the-clock oral dosing with either 600 mg of ibuprofen or 650 mg of acetaminophen every 6 hours. Dosing began within 6 hours after delivery and continued until discharge, with opioid analgesics available as needed for breakthrough pain. Study drugs were encapsulated in identical capsules such that patients, nurses, and physicians were masked to study allocation. Exclusion criteria were serum aspartate aminotransferase or alanine aminotransferase >200 mg/dL, serum creatinine >1.0 mg/dL, infectious hepatitis, gastroesophageal reflux disease, age <18 years, or current incarceration. Our primary outcome was the duration of severe-range hypertension, defined as the time (in hours) from delivery to the last blood pressure ≥160/110 mm Hg. Secondary outcomes were time from delivery to last blood pressure ≥150/100 mm Hg, mean arterial pressure, need for antihypertensive medication at discharge, prolongation of hospital stay for blood pressure control, postpartum use of short-acting antihypertensives for acute blood pressure control, and opioid use for breakthrough pain. We analyzed all outcome data according to intention-to-treat principles. RESULTS: We assessed 154 women for eligibility, of whom 100 met entry criteria, agreed to participate, and were randomized to receive postpartum ibuprofen or acetaminophen for first-line pain control. Seven patients crossed over or did not receive their allocated study drug, and 93 completed the study protocol in their assigned groups. We found no differences in baseline characteristics between groups, including mode of delivery, body mass index, parity, race, chronic hypertension, and maximum blood pressure prior to delivery. We did not find a difference in the duration of severe-range hypertension in the ibuprofen vs acetaminophen groups (35.3 vs 38.0 hours, P = .30). There were no differences between groups in the secondary outcome measures of time from delivery to last blood pressure ≥150/100 mm Hg, postpartum mean arterial pressure, maximum postpartum systolic or diastolic blood pressures, any postpartum blood pressure ≥160/110 mm Hg, short-acting antihypertensive use for acute blood pressure control, length of postpartum stay, need to extend postpartum stay for blood pressure control, antihypertensive use at discharge, or opioid use for inadequate pain control. In a subgroup analysis of patients who experienced severe-range hypertension, the mean time to blood pressure control in the acetaminophen group was 68.4 hours and ibuprofen group was 56.7 hours (P = .26). At 6 weeks postpartum, there were no differences between groups in the rates of obstetric triage visits, hospital readmissions, continued opioid use, or continued antihypertensive use. CONCLUSION: The first-line use of ibuprofen rather than acetaminophen for postpartum pain did not lengthen the duration of severe-range hypertension in women with preeclampsia with severe features.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Blue NR, Murray-Krezan C, Drake-Lavelle S, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. Am J Obstet Gynecol. 2018. PMID: 29505772. doi:10.1016/j.ajog.2018.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。